International audienceIn patients with non-small cell lung cancer (NSCLC) treated with immunotherapy, individual biological and PET imaging prognostic biomarkers have been recently identified. However, combination of biomarkers has not been studied yet. The purpose of this study is to combine clinical, biological and 18FDG PET/CT parameters and use machine-learning algorithms to build more accurate prognostic models of NSCLC response to immunotherap
Purpose: Programmed cell death protein-1 ligand (PD-L1) is an important prognostic predictor for imm...
Background: Predictive markers for treatment response and survival outcome have not been identified ...
We explore both robust biologically guided intensity-modulated radiation therapy (BG-IMRT) and patte...
International audienceIn patients with non-small cell lung cancer (NSCLC) treated with immunotherapy...
Simple Summary The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) i...
We investigated predictions from 18F-FDG PET/CT using machine learning (ML) to assess the neoadjuvan...
The aim of this study was to assess the predictive role of fluorine-18-fluorodeoxyglucose (F-FDG) PE...
Importance: Currently, predictive biomarkers for response to immune checkpoint inhibitor (ICI) thera...
Objectives: Increasing interests have been focused on using artificial intelligence (AI) to extend p...
Introduction Immunotherapy is regarded as one of the major breakthroughs in cancer treatment. Despit...
International audienceThis prospective study aimed (1) to assess the non-small cell lung cancer (NSC...
(1) Background: In advanced non-small cell lung cancer (aNSCLC), programmed death ligand 1 (PD-L1) r...
International audienceBackground: Immune checkpoint inhibitors (ICIs) are now a therapeutic standard...
International audienceBackground: Immune checkpoint inhibitors (ICIs) are now a therapeutic standard...
Background Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated wi...
Purpose: Programmed cell death protein-1 ligand (PD-L1) is an important prognostic predictor for imm...
Background: Predictive markers for treatment response and survival outcome have not been identified ...
We explore both robust biologically guided intensity-modulated radiation therapy (BG-IMRT) and patte...
International audienceIn patients with non-small cell lung cancer (NSCLC) treated with immunotherapy...
Simple Summary The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) i...
We investigated predictions from 18F-FDG PET/CT using machine learning (ML) to assess the neoadjuvan...
The aim of this study was to assess the predictive role of fluorine-18-fluorodeoxyglucose (F-FDG) PE...
Importance: Currently, predictive biomarkers for response to immune checkpoint inhibitor (ICI) thera...
Objectives: Increasing interests have been focused on using artificial intelligence (AI) to extend p...
Introduction Immunotherapy is regarded as one of the major breakthroughs in cancer treatment. Despit...
International audienceThis prospective study aimed (1) to assess the non-small cell lung cancer (NSC...
(1) Background: In advanced non-small cell lung cancer (aNSCLC), programmed death ligand 1 (PD-L1) r...
International audienceBackground: Immune checkpoint inhibitors (ICIs) are now a therapeutic standard...
International audienceBackground: Immune checkpoint inhibitors (ICIs) are now a therapeutic standard...
Background Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated wi...
Purpose: Programmed cell death protein-1 ligand (PD-L1) is an important prognostic predictor for imm...
Background: Predictive markers for treatment response and survival outcome have not been identified ...
We explore both robust biologically guided intensity-modulated radiation therapy (BG-IMRT) and patte...